Aethlon Medical to Merge with North Immunology in All-Stock Deal
Aethlon Medical entered a definitive all-stock merger agreement with North Immunology, alongside an oversubscribed $180 million private placement funding operations into 2028.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.